We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · September 19, 2019

Romiplostim in Patients With Refractory Aplastic Anemia Previously Treated With Immunosuppressive Therapy

The Lancet Haematology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Haematology
Romiplostim in Patients With Refractory Aplastic Anaemia Previously Treated With Immunosuppressive Therapy: A Dose-Finding and Long-Term Treatment Phase 2 Trial
Lancet Haematol 2019 Aug 29;[EPub Ahead of Print], JW Lee, SE Lee, CW Jung, S Park, H Keta, SK Park, JA Kim, IH Oh, JH Jang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading